AVEO Oncology
Founded 2001 · 205 employees on LinkedIn · 1 known investors
Find your way into AVEO Oncology
AVEO, operating as a subsidiary of LG Chem, develops and commercializes oncology medicines aimed at cancer patients seeking effective treatments that maintain quality of life. The company operates a portfolio of on-market and in-development therapeutic products globally.
Founders & leadership
MF
Mike FerraressoinPresident and Chief Executive Officer
Investors · 1
Frequently asked questions
- What does AVEO Oncology do?
- AVEO, operating as a subsidiary of LG Chem, develops and commercializes oncology medicines aimed at cancer patients seeking effective treatments that maintain quality of life. The company operates a portfolio of on-market and in-development therapeutic products globally.
- Who are AVEO Oncology's investors?
- AVEO Oncology's investors include New Enterprise Associates (NEA).